Smruthi Organics Limited, founded in 1989, is a leading Active Pharmaceutical Ingredients (API) and Intermediates manufacturing company based in Solapur, Maharashtra, India. With over 30 years of experience, the company is listed on the Bombay Stock Exchange (BSE). Smruthi operates 2 API manufacturing facilities in Solapur and specializes in the production of key products such as Metformin (anti-diabetic), Diloxanide Furoate (anti-amoebic), Amlodipine Besilate, Telmisartan, Losartan (anti-hypertensive), and Norfloxacin (anti-bacterial). Being a prominent player in the Manufacturing and Pharmaceutical industries, Smruthi Organics Limited has positioned itself as a key contributor in the healthcare sector. Currently, there is no available information regarding the company's latest investment or the involved investors.
There is no investment information
No recent news or press coverage available for Smruthi Organics Limited.